SHARPIN and lung carcinoma: We demonstrate that the interaction with SHARPIN with a novel cofactor PRMTA5 plays biological roles in tumor progression and invasion via regulating a unique histone H3R2 methylation-coupled transcriptional activation in lung cancer cells.